CHICAGO (Reuters) - Allergan Inc said on Thursday that its popular Botox facial wrinkle-smoother worked as a treatment for adults suffering from chronic migraines, according to late-stage clinical ...
Allergan Inc. saw a smoother first quarter for Botox and sales of other medical cosmetic products, which took a hit during the recession. Stronger sales of wrinkle-fighting Botox as well as skin ...
(Reuters) - Botox maker AbbVie Inc's Allergan unit has accused Revance Therapeutics Inc in a federal lawsuit of poaching key employees in a "desperate" effort to compete in the market for anti-wrinkle ...
IRVINE, Calif., Sept. 11, 2024 /PRNewswire/ -- Allergan Aesthetics, an AbbVie (ABBV) company, today announced that BOTOX ® Cosmetic (onabotulinumtoxinA) is now available for the treatment of masseter ...
The current stock price likely implies Botox declines, but we think the franchise can maintain healthy growth as a result of expansion of the market and limited price competition. Firms Likely to Have ...
Consumers Can Apply for a Chance to Be Featured in Upcoming Campaigns for BOTOX ® Cosmetic, the JUVÉDERM ® Collection of Fillers, and Allē, the Allergan Aesthetics Loyalty Rewards Program "We are ...
Jan 4 (Reuters) - A federal judge on Wednesday said Botox maker AbbVie's ABBV.N Allergan unit can move ahead with its lawsuit accusing Revance Therapeutics RVNC.O of taking its confidential data to ...
Allergan, the maker of eye and skin drugs as well as wrinkle-reducing Botox and other medical cosmetics, posted solid 2010 revenue growth as the economy continued its recovery. In late 2010, Allergan ...
NEW YORK (AP) — Valeant Pharmaceuticals has teamed up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion. Valeant said Monday that it intends to ...
Federal officials are trying to determine the source of Botox injections — some of the shots potentially counterfeits — linked to an outbreak of botulism-like illnesses in several U.S. states. The ...
BOTOX® Cosmetic is the first neurotoxin approved in China for the treatment of masseter muscle prominence (MMP), the largest global market for MMP. Approval supported by well-established safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback